Literature DB >> 11893747

Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor.

Kaleeckal G Harikumar1, Delia I Pinon, William S Wessels, Franklyn G Prendergast, Laurence J Miller.   

Abstract

Fluorescence is a powerful biophysical tool for the analysis of the structure and dynamics of proteins. Here, we have developed two series of new fluorescent probes of the cholecystokinin (CCK) receptor, representing structurally related peptide agonists and antagonists. Each ligand had one of three distinct fluorophores (Alexa(488), nitrobenzoxadiazolyl, or acrylodan) incorporated in analogous positions at the amino terminus just outside the hormone's pharmacophore. All of the probes bound to the CCK receptor specifically and with high affinity, and intracellular calcium signaling studies showed the chemically modified peptides to be fully biologically active. Quenching by iodide and measurement of fluorescence spectra, anisotropy, and lifetimes were used to characterize the response of the fluorescence of the probe in the peptide-receptor complex for agonists and antagonists. All three fluorescence indicators provided the same insights into differences in the environment of the same indicator in the analogous position for agonist and antagonist peptides bound to the CCK receptor. Each agonist had its fluorescence quenched more easily and showed lower anisotropy (higher mobility of the probe) and shorter lifetime than the analogous antagonist. Treatment of agonist-occupied receptors with a non-hydrolyzable GTP analogue shifted the receptor into its inactive low affinity state and increased probe fluorescence lifetimes toward values observed with antagonist probes. These data are consistent with a molecular conformational change associated with receptor activation that causes the amino terminus of the ligand (situated above transmembrane segment six) to move away from its somewhat protected environment and toward the aqueous milieu.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893747     DOI: 10.1074/jbc.M201164200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Modulation of cell surface expression of nonactivated cholecystokinin receptors using bivalent ligand-induced internalization.

Authors:  Kaleeckal G Harikumar; Eyup Akgün; Philip S Portoghese; Laurence J Miller
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

2.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

3.  Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor.

Authors:  Kaleeckal G Harikumar; Erin E Cawston; Laurence J Miller
Journal:  Assay Drug Dev Technol       Date:  2011-03-11       Impact factor: 1.738

Review 4.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

5.  Monitoring the state of cholecystokinin receptor oligomerization after ligand binding using decay of time-resolved fluorescence anisotropy.

Authors:  Kaleeckal G Harikumar; Laurence J Miller
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

6.  Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells.

Authors:  S J Briddon; R J Middleton; Y Cordeaux; F M Flavin; J A Weinstein; M W George; B Kellam; S J Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

7.  Pharmacology and direct visualisation of BODIPY-TMR-CGP: a long-acting fluorescent beta2-adrenoceptor agonist.

Authors:  Jillian G Baker; Ian P Hall; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

8.  Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor.

Authors:  Kaleeckal G Harikumar; Fan Gao; Delia I Pinon; Laurence J Miller
Journal:  Biochemistry       Date:  2008-08-13       Impact factor: 3.162

9.  Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands.

Authors:  Jillian G Baker; Richard Middleton; Luke Adams; Lauren T May; Stephen J Briddon; Barrie Kellam; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2010-01-26       Impact factor: 8.739

Review 10.  Homology modelling and spectroscopy, a never-ending love story.

Authors:  Hanka Venselaar; Robbie P Joosten; Bas Vroling; Coos A B Baakman; Maarten L Hekkelman; Elmar Krieger; Gert Vriend
Journal:  Eur Biophys J       Date:  2009-08-29       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.